ENTPD1 and colorectal cancer: The expression of PD-1 and CD39 has recently been described in neoantigen-specific tumor-infiltrating lymphocytes (TILs) from colorectal cancer patients, and CD39 has been proposed as a marker for tumor-specific T cells [17, 29].